Who is protected? Determinants of hepatitis B infant vaccination completion among a prospective cohort of migrant workers in Thailand during the COVID-19 pandemic.
Chiang Mai
Documentation
EPI
Health services
Immunization
Mae Sot
Migration
Myanmar
Tak
Journal
International journal for equity in health
ISSN: 1475-9276
Titre abrégé: Int J Equity Health
Pays: England
ID NLM: 101147692
Informations de publication
Date de publication:
30 12 2022
30 12 2022
Historique:
received:
17
02
2022
accepted:
30
11
2022
entrez:
30
12
2022
pubmed:
31
12
2022
medline:
4
1
2023
Statut:
epublish
Résumé
Hepatitis B causes significant disease and death globally, despite the availability of effective vaccination. Migration likewise affects hundreds of millions of people annually, many of whom are women and children, and increases risks for poor vaccine completion and mother to child transmission of hepatitis B. In the neighbouring countries of Thailand and Myanmar, vaccine campaigns have made progress but little is known about the reach of these programs into migrant worker communities from Myanmar living in Thailand. A cohort of 253 postpartum women (53 urban migrants in Chiang Mai and 200 rural migrants in Tak Province) were surveyed about their Hepatitis B knowledge and willingness to vaccinate their children between September 10, 2019 and March 30, 2019. They were subsequently followed to determine vaccine completion. When records of vaccination were unavailable at the birth facility, or visits were late, families were contacted and interviewed about vaccination elsewhere, and reasons for late or missed vaccines. Though women in Tak province displayed better knowledge of Hepatitis B and equal intention to vaccinate, they were 14 times less likely to complete Hepatitis B vaccination for their children compared to migrants in Chiang Mai. Tak women were largely undocumented, had private (non-profit) insurance and had more transient residence. In Chiang Mai migrant women were mostly documented and had full access to the Thai national health services. Though minor individual and facility-level differences may have contributed, the major driver of the disparity seems to be the place of migrants within local socio-political-economic systems. The COVID-19 pandemic further disproportionately affected Tak province migrants who faced severe travel restrictions hampering vaccination. Sixty percent of families who were lost to vaccine follow-up in Tak province could not be contacted by phone or home visit. Chiang Mai migrants, with 86.8% vaccine completion, nearly reached the target of 90%. Achievement of high levels of hepatitis B vaccination in migrant communities is important and feasible, and requires inclusive policies that integrate migrants into national health and social services. This is more urgent than ever during the COVID-19 era.
Sections du résumé
BACKGROUND
Hepatitis B causes significant disease and death globally, despite the availability of effective vaccination. Migration likewise affects hundreds of millions of people annually, many of whom are women and children, and increases risks for poor vaccine completion and mother to child transmission of hepatitis B. In the neighbouring countries of Thailand and Myanmar, vaccine campaigns have made progress but little is known about the reach of these programs into migrant worker communities from Myanmar living in Thailand.
METHODS
A cohort of 253 postpartum women (53 urban migrants in Chiang Mai and 200 rural migrants in Tak Province) were surveyed about their Hepatitis B knowledge and willingness to vaccinate their children between September 10, 2019 and March 30, 2019. They were subsequently followed to determine vaccine completion. When records of vaccination were unavailable at the birth facility, or visits were late, families were contacted and interviewed about vaccination elsewhere, and reasons for late or missed vaccines.
RESULTS
Though women in Tak province displayed better knowledge of Hepatitis B and equal intention to vaccinate, they were 14 times less likely to complete Hepatitis B vaccination for their children compared to migrants in Chiang Mai. Tak women were largely undocumented, had private (non-profit) insurance and had more transient residence. In Chiang Mai migrant women were mostly documented and had full access to the Thai national health services. Though minor individual and facility-level differences may have contributed, the major driver of the disparity seems to be the place of migrants within local socio-political-economic systems. The COVID-19 pandemic further disproportionately affected Tak province migrants who faced severe travel restrictions hampering vaccination. Sixty percent of families who were lost to vaccine follow-up in Tak province could not be contacted by phone or home visit. Chiang Mai migrants, with 86.8% vaccine completion, nearly reached the target of 90%.
CONCLUSIONS
Achievement of high levels of hepatitis B vaccination in migrant communities is important and feasible, and requires inclusive policies that integrate migrants into national health and social services. This is more urgent than ever during the COVID-19 era.
Identifiants
pubmed: 36585709
doi: 10.1186/s12939-022-01802-5
pii: 10.1186/s12939-022-01802-5
pmc: PMC9803398
doi:
Substances chimiques
Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
190Informations de copyright
© 2022. The Author(s).
Références
PLoS One. 2016 Oct 6;11(10):e0164363
pubmed: 27711144
PLoS One. 2017 Jun 2;12(6):e0178671
pubmed: 28575040
BMC Public Health. 2018 Aug 8;18(1):987
pubmed: 30089475
Int J Environ Res Public Health. 2019 Jul 19;16(14):
pubmed: 31330995
Open Forum Infect Dis. 2019 Dec 07;6(12):ofz518
pubmed: 31890723
BMC Med Inform Decis Mak. 2010 Nov 03;10:69
pubmed: 21047412
Bull World Health Organ. 2011 Jul 1;89(7):528-31
pubmed: 21734767
J Immigr Minor Health. 2016 Oct;18(5):1038-1045
pubmed: 26483180
PLoS One. 2013 Aug 22;8(8):e72721
pubmed: 23991145
Hum Vaccin Immunother. 2020 Jul 2;16(7):1485-1497
pubmed: 32271649
BMC Pregnancy Childbirth. 2021 Jul 23;21(1):525
pubmed: 34301179
PLoS One. 2016 Mar 03;11(3):e0150499
pubmed: 26938736
World J Gastroenterol. 2015 Nov 14;21(42):11941-53
pubmed: 26576083
Korean J Hepatol. 2011 Jun;17(2):87-95
pubmed: 21757978
Lancet. 2015 Sep 12;386(9998):1013
pubmed: 26382976
EClinicalMedicine. 2021 May 29;36:100904
pubmed: 34124633
J Infect Dev Ctries. 2019 Feb 28;13(2):169-173
pubmed: 32036354
BMC Pregnancy Childbirth. 2015 Feb 05;15:17
pubmed: 25652646
Lancet. 2017 Mar 4;389(10072):964-977
pubmed: 28271847
Trop Med Infect Dis. 2020 May 12;5(2):
pubmed: 32408591
BMC Pregnancy Childbirth. 2021 Dec 2;21(1):802
pubmed: 34856954
J Infect Dev Ctries. 2016 Apr 28;10(4):384-8
pubmed: 27131000
F1000Res. 2014 Jun 10;3:123
pubmed: 26664698
PLoS One. 2020 Apr 2;15(4):e0230407
pubmed: 32240176
Lancet. 2021 Aug 7;398(10299):522-534
pubmed: 34273292
Vaccines (Basel). 2020 Feb 05;8(1):
pubmed: 32033393